"Clinical Trials exploring the potential of DM-199 in human settings are the next logical step."
Dr. Paul Burn, The Broin Chair & Director of The Sanford Project
As seen in this document issued by the Center for Disease Control (CDC), 8.3% of the US population currently has diabetes while over 25% of the...
DiaMedica was featured in BioTuesday regarding the impressive data in the Company's diabetes programs: ...
BBC© MMX Tuesday, 3 February 2010
The most common form of dementia may be closely related to another common disease of old-age...
(Reuters) - Insulin appears to shield the brain from toxic proteins associated with Alzheimer's disease, U.S. researchers said on Monday,...
January 22, 2010 VIVIAN SONG SPECIAL TO THE TORONTO STAR
Katherine's father is battling dual enemies in the twilight of his...
Science & Technology May 18, 2009 Volume 87, Number 2
Disruptions of insulin signaling and glucose regulation contribute to...
The idea came from the metabolism of migrating birds
WASHINGTON - People with Type 2 diabetes may soon get a very different treatment...
DMA STOCK QUOTE
Request Investor Information
View Corporate Fact Sheet
